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ABSTRACT
Background and Objectives: Obesity and overweight are major determinants of health and quality of life. 
The World Health Organization (WHO) has always encouraged its member states to carry out studies on the 
attributable burden of these diseases at the national level, and use the study as the best guide to direct the health 
system policy. This study was thus undertaken in order to determine the regional burden of non-communicable 
diseases due to obesity and overweight. Setting and Design: Counterfactual analysis of the death registration 
data in Markazi province of Iran was carried out. Materials and Methods: We calculated the Years of Life 
Lost (YLL) according to the WHO’s comparative risk assessment approach. Moreover, the attributable burden 
of obesity and overweight was determined by multiplying the impact fraction of risk factors with the YLL 
of major diseases, and the counterfactual analysis method was used. Results: A total of 7,176 deaths were 
registered contributing to 252,214 YLL, due to premature mortality. The total YLL due to premature mortality 
among females and males were 102,245 and 149,969 years, respectively. The most important causes of the 
YLL were associated with obesity and overweight in cardiovascular diseases for females, and overweight in 
cardiovascular diseases for males (12,826, 8,755 and 7,375 years, respectively). Conclusion: In this study, 
the importance and necessity of the recognition of overweight and obesity as the major risk factors for  
non-communicable diseases was shown. Hence, it is necessary to develop and apply comprehensive interventions 
to reduce the effect of overweight and obesity, especially in females.
Key words: Attributable risk, burden of diseases, non-communicable diseases, obesity, overweight
Estimation of the regional burden of non-communicable diseases 
due to obesity and overweight in Markazi province, Iran,  
2006-2007
Jafar Hassanzadeh1, Abolfazl Mohammadbeigi1,2, Babak Eshrati3, Mohammad Djaefar 
Moemenbellah-Fard4
1Department of Epidemiology, School of Health and Nutrition, Research Centre for Health Sciences, 
Shiraz University of Medical Sciences, Shiraz, 2PhD Student of Epidemiology, Qom University of Medical 
Sciences, Qom,3PhD in Epidemiology, Molecular and Medicine Research Center of Arak University 
of Medical Sciences, Arak, 4Department of Medical Entomology, School of Health and Nutrition, 
Research Centre for Health Sciences, Shiraz University of Medical Sciences, Shiraz, Iran
Address for correspondence: Dr. Abolfazl Mohammadbeigi, Department of Epidemiology, School of Health, 
Qom, Iran, E-mail: beigi60@gmail.com
JCDR
INTRODUCTION
In many countries of the Middle East region, the incidence 
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of Non-Communicable Diseases (NCDs) is ever increasing 
as a result of prolonged life spans, increasingly longer 
exposures to risk factors and changing patterns of life 
styles.[1] NCDs mortalities were, in fact, three times greater 
than those due to infectious diseases in this region about 
two decades ago.[2] Obesity and overweight are two of the 
most important determinants of health and the quality of 
life in the global burden of disease (GBD) epidemics.[3,4] 
These are the third most likely (7.2%) risk factors associated 
with NCDs and injuries leading to the loss of healthy life 
among rich nations.[5] For instance, cardiovascular diseases 27 Journal of Cardiovascular Disease Research Vol. 3 / No 1
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(CVDs) are the leading cause of death among NCDs, 
and their annual mortality rate among the population 
over 40-years old is estimated as 1.4% in Iran.[6] The 
traditional metrics’ system had numerous shortcomings 
in determining the health status of the community and 
could not properly supply to the needs of a community 
study. [7] Therefore, in the second half of the 20th century, 
it was deemed as necessary to adopt a correct decision 
making system and strengthen the heakth policies. This 
would even enable obtaining precise data on mortalities, 
injuries, diseases, incidence rates, and their outcomes, 
causes and trends. Therefore, a set of metrics was required 
with which damages due to premature mortality and 
morbidity from different diseases could be expressed in the 
context of a common metric, such that, both the health 
status of individuals and the community distribution of 
the disease conditions could be manifested in a limited 
number of quantitative metrics.[7,8] The application of new 
summary metrics such as life expectancy, disability-free 
life expectancy, and Disability Adjusted life Years (DALY) 
would also be effective in such a system.[9] In order to the 
help managers and policy-makers of the community, these 
metrics should be able to express – in terms of priority 
and funding – the burden of mortality and morbidity 
from diseases and injuries in a conceivable way, so that 
appropriate actions could b taken accordingly.[8]
DALY expands the concept of Years of Life Lost (YLL) 
due to premature mortality to the years of life lost due to 
morbidity due to health problems. DALY is the sum of 
the YLL due to premature mortality and Years of Life 
lived with Disability (YLD), due to nonfatal outcomes of 
diseases and injuries in the community.[10] WHO encourages 
member states to estimate the burden of diseases at the 
national level as the best guide to the correct policy-making 
of health systems.[11] The main aim of this study was to 
determine the regional burden of NCDs attributable to 
obesity and overweight in Markazi province, Iran.
MATERIALS AND METHODS
Study area
This study was carried out in Markazi province, Iran during 
2006-2007. The surface area of this province is 29,530 km2 
which represents only 1.82% of the whole country. It is an 
industrialized region located 293 km southwest of Tehran, 
the capital. In the latest census which was carried out in 
2006, a sum of 1,351,257 people lived in this province with 
682,367 males (50.49%) and 668,890 females (49.51%).[12] 
The average life expectancy in this province was 72.6 years 
for females and 68.86 years for males based on the death 
registration system data in 2004.[13]
Data collection
The mortality data provided in this study was collected 
by referring to the death registration system run by the 
Provincial Health Authority (PHA). All sources of diagnosis, 
detection, recording and collection of data including 
hospitals, forensic medicine centers, cemetery, and provincial 
or local health authorities were used to complete the data. 
In this system, intersectional cooperation ensured that 
all mortality data were gathered in each district and were 
dispatched to the PHA. A standard questionnaire, which 
included questions pertaining to the cause of the death of 
the individual – as per the findings of the death certificate, 
or if no certificate was present, as per findings of oral 
autopsy – was completed by a relative under the supervision 
of a health investigator. The questionnaire was then encoded 
according to the International Classification of Diseases 
(ICD10) guidelines at the PHA, was and was registered in 
the computer.Calculation of the attributable burden was 
performed in three consecutive stages. First, the YLL was 
computed[14] according to the Comparative Risk Assessment 
(CRA) method of the World Health Organization. This 
involved a standardized life table in which life expectancy 
at birth was considered to be 82.5 years for females, and 80 
years for males. In the second stage, the generalized impact 
factor (GIF) was calculated based on the percentage of the 
risk factors in the following formula.[15-17] For all diseases, the 
minimum counterfactual risk scenario was taken to be zero.[17]
GIF formula:
In the above formula, RR is the estimate of the relative 
risk and P reflects the prevalence of the exposure in the 
population. Finally, after calculating the YLL and GIF based 
on the counterfactual analysis with the CRA approach, these 
parameters were multiplied to obtain the attributable burden 
of obesity and overweight of some NCDs including CVDs 
such as hypertension, stroke, diabetes (Type 1 and 2), and 
some cancers (stomach, lung, liver, leukemia, esophageal, 
colon, breast, and Renal). Obesity is defined as the Body 
Mass Index (BMI) equal to 30 kg/m2 or more. Besides, 
overweight is considered as the BMI between 25 and 30 
kg/m2.[18] All calculations were conducted in the Statistical 
package for Social Sciences (SPSS) statistical software 
(version 11.5) and the Microsoft Office Excel 2007.
(%)=
] 100 1 ) 100 [ ) (× × − + ×P R P
) 1 ) 100 ( (× − tual counterfac
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RESULTS
A total of 7,176 deaths were registered in Markazi province 
in 2006. This caused 252,214 YLL among all the people of 
this region. 39.6% percent (2,837 deaths) of these deaths 
were seen in females. The total YLL for premature deaths 
in females and males were 102,245 (40.5%) and 149,969 
(59.5%) years, respectively. Thus, the ratio of male YLL 
to female YLL was around 1.47. The ten major causes of 
YLL due to premature deaths in this province in the order 
of importance were: CVDs (40.89%); injuries and accidents 
(17.61%); cancers (10.46%); respiratory system diseases 
(6.48%); geriatric conditions (4.09%); congenital defects 
and peri-natal diseases (3.46%); genitourinary diseases 
(2.46%); endocrine and metabolic diseases (2.05%); 
nervous system disorders (1.86%); and, gastrointestinal 
diseases (1.59%). Altogether, these accounted for 90.98% 
of the total YLL due to premature death in this province. 
These causes of the YLL were sorted with respect to 
their priority on the 17 causes of disease categorization in 
GBD [Table 1]. The YLL and YLL per thousand values in 
males and females for twelve under-study diseases, which 
were ranked based on their importance in the YLL, were 
tabulated separately [Table 2]. According to these results, 
brain stroke got the highest rank, while renal cancer was 
on the bottom.
The attributable burden of overweight and obesity in 
diseases under the study is shown in Table 3. According 
to these findings, the three main factors involved in YLL 
due to premature death were obesity and overweight in 
coronary artery disease among females (12,826 and 8,755), 
and overweight in coronary artery disease among males 
(7,375). These results indicated that the attributable burden 
of obesity and overweight in cancers was less than that in 
CVD, hypertension, stroke, and diabetes. The minimum 
attributable burden was related to obesity, and esophageal 
and colon cancers in males.
DISCUSSION
This study showed that nearly 91% of the total burden 
Table 1: Estimated years of life lost of non-communicable disease in Markazi province of I.R. Iran
Row YLL →
Disease ↓
Female Male Total
YLL YLL per 1000 YLL YLL per 1000 YLL YLL per 1000
1 Cardiovascular diseases 50135 74.95 53015 77.69 103149 76.33
2 Accidents and injuries 11157 16.67 33259 48.74 44416 32.86
3 Cancers 10141 15.16 16232 23.79 26373 19.52
4 Respiratory system diseases 6170 9.22 10181 14.92 16351 12.1
5 Aging and bad signs 5071 7.58 5254 7.7 10325 7.64
6 Congenital and prenatal 
malformations
3443 5.15 5295 7.76 8738 6.47
7 Genitourinary diseases 2521 3.77 3707 5.43 6229 4.61
8 Endocrine and metabolic 
diseases
3104 4.64 2060 3.02 5164 3.82
9 Nervous system diseases 1991 2.98 2710 3.97 4702 3.48
10 Gastrointestinal diseases 1734 2.59 2275 3.33 4009 2.97
Total 95467 142.72 133989 196.36 229456 169.81
Where, YLL = Years of Life Lost
Table 2: Years of life lost due to premature death for diseases under the study 
Row YLL →
Disease ↓
Female Male Total
YLL YLL per 1000 YLL YLL per 1000 YLL YLL per 1000
1 Brain stroke 13660 20.42 14510 21.26 28090 20.78
2 Hypertension 8916 13.33 7759 11.37 16675 12.34
3 Stomach cancer 1659 2.48 3245 76.4 4904 3.63
4 Diabetes 2349 3.51 1573 2.31 3922 2.9
5 Lung cancer 1026 1.53 2554 3.74 3580 2.65
6 Liver cancer 1376 2.06 1754 2.57 3130 2.32
7 Leukemia 1537 20.30 1564 2.29 3103 2.29
8 Esophageal cancer 272 0.407 483 0.708 755 0.56
9 Colon cancer 393 0.587 293 0.429 686 0.507
10 Breast cancer 629 0.940 36 0.05 665 0.492
11 Renal cancer 166 0.248 149 0.218 315 0.233
Where, YLL = Years of Life Lost29 Journal of Cardiovascular Disease Research Vol. 3 / No 1
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of diseases was related to ten main causes. and that the 
highest burden of the YLL due to premature death was 
related to coronary heart diseases, cancer, and accidents. 
Mousavi et al.[11] conducted a study in Zanjan province, 
in the northwest of Iran, and obtained similar results. In 
their study, cardiovascular diseases, unintentional injuries, 
and malignancies were listed as three major causes of the 
premature death. Our study showed that the YLL in males 
is approximately 1.5 times higher than that of females, but 
this ratio was calculated as 1.8 in Mousavi’s study. In a study 
on global and regional burden of diseases in 2001, heart 
diseases were ranked as the third leading causes of GBD. 
Moreover, prenatal birth conditions and lower respiratory 
system infections held the first and second positions, 
respectively.[5] Also, in the study performed by Ezzati   
et al., hypertension had the third rank among the causes 
of the GBD that contributed to 4.4% of the total burden 
of diseases.[19]
In the study by Lopez et al. on the measurement of 
GBD and epidemiological transition of diseases, heart 
diseases and stroke held the sixth and seventh positions, 
respectively. Based on a forecast of 2030, heart diseases 
will become the first cause.[20] However, the NCDs were 
ranked as the 15th in 1990.[1] Therefore, according to the 
results of the current study, it seems that the severity and 
the extent of CVD in reducing the useful years of life is 
faster in Markazi Province than the global forecast. Our 
results showed that the major factors of the YLL among 
males and females are overweight attributed to CVD and 
obesity attributed to CVD, respectively. Also, regarding 
the role of overweight, there is not much difference 
between males and females; however, the role of obesity 
among females is highlighted. These results might be 
due to the high prevalence of obesity and overweight 
in females compared to males in Markazi province[21] or 
other places.[22]
In the population attributable risk study about the effect 
of the body mass index (BMI) higher than 25 on the 
cancer mortality among 30 European countries in 2002, 
this risk was estimated to be 2.5% for males and 4.1% 
for females. According to the estimations made in 2008, 
the population attributable risk for cancer mortality from 
Table 3: Attributable burden of overweight and obesity for diseases under the study
Diseases Risk factor Factor effect 
#(RR)
Prevalence 
of exposure ##
Generalized impact 
factor (GIF %)
Attributable 
burden
Hypertension Cardiovascular 
diseases
Overweight-male 2.35 5.2 6.56 1094
Overweight-female 2.35 14.2 16.09 2682
Obesity-male 1.4 2.8 1.11 185
Obesity-female 2 0.4 0.398 66
Brain stroke Overweight-male 1.35 2.1 0.729 205
Overweight-female 1.25 26.5 6.21 1745
Obesity-male 1.5 5.2 2.53 712
Obesity-female 1.6 14.2 7.85 2205
Total Overweight-male 1.35 22.1 7.15 7375
Overweight-female 1.35 26.5 8.49 8755
Obesity-male 1.8 5.2 3.99 4120
Obesity-female 2 14.2 12.43 12826
Esophageal 
cancer
Cancer Obesity-male 1.1 5.2 0.517 4
Obesity-female 1.1 14.2 1.4 11
Colon cancer Overweight-male 1.15 22.1 3.21 22
Overweight-female 1.33 26.5 8.04 55
Obesity-male 1.15 5.2 0.773 5
Obesity-female 1.33 14.2 4.476 31
Renal cancer Overweight-male 1.36 22.1 7.37 23
Overweight-female 1.36 26.5 8.71 27
Obesity-male 1.84 5.2 4.18 13
Obesity-female 1.84 14.2 10.66 34
Breast cancer Overweight-female 1.12 26.5 3.08 20
Obesity-female 1.25 14.2 3.43 23
Diabetes Diabetes Overweight-male 1.8 22.1 3.99 157
Overweight-female 1.8 26.5 10.2 400
Obesity-male 3.2 5.2 32.61 1279
Obesity-female 3.2 14.2 43.5 1706
#used from reference no. 26, ## used from reference no. 2230 Journal of Cardiovascular Disease Research Vol. 3 / No 1
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this risk factor was also calculated to be 3.2% and 8.6% 
for males and females, respectively.[23] This is consistent 
with our results; in a way that the role of overweight 
and obesity among females was higher in increasing the 
attributable burden. The overall burden of breast cancer 
due to the early death in Yazd province[24] was obtained as 
461 years. This was based on the study population – equal 
to 0.97 YLL per 1000 people. However, in our study, these 
measures were equal to 665 years and 0.492, respectively. 
It indicated that among Yazd population, the YLL due to 
the breast cancer was twice as much as our community. 
However in a study in the Eastern Mediterranean,[25] this 
risk was calculated as 0.488 which was similar to our 
results. Therefore, it is noteworthy that the YLL in the 
population under our study is more than the amount 
calculated for the whole country in 2003. Abolhassani   
et al.[8] calculated this ratio as 0.25. However, these differences 
between the two studies, on Markazi and Yazd provinces, 
may be the results of different methods employed in order 
to obtain the YLL. Vakili did not state how he calculated the 
YLL in his study. Also, as mentioned, this difference can be 
justified since the age standardized incidence ratio in Yazd 
province is higher than the whole country.
Our study had limitations. First, due to the availability 
and the need for more valid data on YLL, we decided 
to use only premature death data, and thus we could 
not contribute to YLD in the burden of diseases. Also, 
in calculating the GIF, the hypothetical scenario was 
set as zero which can lead to the overestimation of the 
attributable burden.
CONCLUSION
Based on the results of recent studies,[8,13] the attributable 
burden of overweight and obesity related to CVD is more 
prominent than other diseases. Moreover, the calculated 
burden in Markazi province is higher than other provinces. 
Females are at greater risk from obesity. Therefore, the 
prevention and the control of obesity – as a major health 
risk factor, particularly among females – is essential.[26] 
These findings support the need for development and 
implementation of comprehensive interventions to 
reduce the effect of overweight and obesity.
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